Caption Management’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.4M	Buy	61,800 +36,800	+147%	+$6.36M	0.5%	324
2025 Q4	$4.57M	Hold	25,000	–	–	0.2%	549
2025 Q3	$3.04M	Hold	25,000	–	–	0.18%	666
2025 Q2	$2.61M	Hold	25,000	–	–	0.24%	637
2025 Q1	$2.92M	Sell	25,000 -195,000	-89%	-$22.2M	0.13%	565
2024 Q4	$18.6M	Buy	+220,000	New	+$20.2M	0.77%	90
2024 Q2	–	Sell	-32,900	Closed	-$2.63M	–	1185
2024 Q1	$2.63M	Buy	+32,900	New	+$2.76M	0.29%	460
2023 Q3	–	Sell	-27,500	Closed	-$1.98M	–	1293
2023 Q2	$1.98M	Sell	27,500 -2,500	-8%	-$184K	0.35%	497
2023 Q1	$1.85M	Sell	30,000 -5,000	-14%	-$328K	0.4%	460
2022 Q4	$2.7M	Buy	+35,000	New	+$2.09M	0.46%	479
2022 Q3	–	Sell	-20,000	Closed	-$766K	–	1514
2022 Q2	$766K	Sell	20,000 -209,000	-91%	-$6.61M	0.07%	959
2022 Q1	$9.48M	Buy	229,000 +56,000	+32%	+$1.74M	0.63%	226
2021 Q4	$6.54M	Hold	173,000	–	–	0.41%	374
2021 Q3	$5.7M	Buy	+173,000	New	+$6.74M	0.37%	397
2020 Q2	–	Sell	-306,400	Closed	-$18M	–	949
2020 Q1	$18M	Buy	+306,400	New	+$25M	5.88%	6